Pacira BioSciences, Inc.
For the period ended Jan 8, 2026. Filed Jan 8, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jan 8, 2026 · Filed Jan 8, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Share Repurchase Program
Share Repurchase Program
During the fourth quarter of 2025, the company repurchased 2.0 million shares of its common stock through open market transactions for $50.0 million (exclusive of broker fees and excise tax incurred). At December 31, 2025, the company had 41.1 million shares of common stock outstanding and $150.0 million remaining on its current share repurchase authorization, which expires December 31, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.